Results 51 to 60 of about 847 (177)

Tricuspid Transcatheter Edge‐to‐Edge Repair Trends and Predictors of Outcomes: Insight From National Inpatient Sample Database

Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.
Background Severe tricuspid regurgitation (TR) is associated with significant morbidity and mortality and has limited treatment options. Surgical intervention is often contraindicated due to high perioperative risk, creating a demand for minimally invasive alternatives like tricuspid transcatheter edge‐to‐edge repair (T‐TEER).
Sameh Nassar, Zahoor Khan, Amanda Nguyen, Muhammad Zia Khan, Salman Zahid, Waleed Alruwaili, Richard Kovach, Chunguang Chen, Muhammad Raza, Irfan Ahmad   +9 more
wiley   +1 more source

Transcatheter Tricuspid Valve Replacement in Patients After Prior Left‐Sided Valve Surgery: A Multicenter Retrospective Analysis

Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.
Background Functional tricuspid regurgitation (TR) after previous left‐sided valve surgery (LSVS) represents a significant proportion of all isolated TR cases; tricuspid valve reoperation in such patients, often in the advanced stage of disease, is historically regarded as high‐risk.
Tianyuan Xiong, Yi Zhang, Fan Qiao, Yuan Feng, Zhengang Zhao, Xin Wei, Xi Li, Fei Chen, Xingyu Ji, Junbo Ge, Fanglin Lu, Mao Chen, Irfan Ahmad   +12 more
wiley   +1 more source

Innovative medical technologies in the percutaneous treatment of tricuspid regurgitation in Poland

Cardiology Journal, 2022
Tricuspid regurgitation (TR) usually develops secondarily to left-sided heart diseases, whereas primary lesions to the valve apparatus is less common. Untreated severe TR has a poor prognosis and surgical treatment, i.e., valve repair or replacement, is ...
Adam Witkowski, Dariusz Dudek, Stanisław Bartuś, Wojciech Wojakowski, Andrzej Gackowski, Marek Grygier, Mariusz Kuśmierczyk, Miłosz J. Jaguszewski, Ewa Kowalik, Katarzyna Bondaryk, Maciej Niewada, Piotr Przygodzki, Michał Jakubczyk   +12 more
doaj   +1 more source

Initial Results after the Implementation of an Edge-To-Edge Transcatheter Tricuspid Valve Repair Program

, 2021
Transcatheter tricuspid valve repair (TTVr) has emerged as an alternative for the treatment of severe tricuspid regurgitation (TR). We report our initial experience with an edge-to-edge TTVr system in a high-volume institution.
Juan Carlos de la Fuente Mancera, Marta Farrero, Laura Sanchis, Ander Regueiro, Salvatore Brugaletta, Marta Sitges, Xavier Freixa, Joan Guzman Bofarull, Cristina Ibañez, Pedro Luis Cepas-Guillen, Manel Sabate   +10 more
core   +1 more source

Advancements in transcatheter tricuspid valve repair and replacement: a state-of-the-art review with echocardiographic outcomes

Global Cardiology
Tricuspid regurgitation (TR) affects over 1.6 million individuals in the United States, with a one-year mortality rate of 36.1% and a five-year survival below 30%.
Asad Gul Rao, Syed Sarmad Javaid, Ahmed Mustafa Rashid, Fawaz Alenezi   +3 more
doaj   +1 more source

Treatment of severe tricuspid regurgitation induced by permanent pacemaker lead: Transcatheter tricuspid valve replacement with the guidance of 3-dimensional printing

Frontiers in Cardiovascular Medicine, 2023
BackgroundLead-induced tricuspid regurgitation is one of the complications after permanent pacemaker implantation (PPI) and refers to tricuspid regurgitation (TR) caused by the lead in the right ventricle (RV).ObjectivesTo study the clinical ...
Yu Mao, Yang Liu, Xin Meng, Yanyan Ma, Lanlan Li, Mengen Zhai, Ping Jin, Fanglin Lu, Jian Yang   +8 more
doaj   +1 more source

Worsening versus advanced heart failure: Management and challenges

ESC Heart Failure, Volume 12, Issue 6, Page 3856-3868, December 2025.
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli, Marco Giuseppe Del Buono, Giulia La Vecchia, Stephen J. Greene, Andrew P. Ambrosy, Ovidiu Chioncel, Finn Gustafsson, Selim R. Krim, Carl J. Lavie, Marianna Adamo, Tuvia Ben Gal, Oliviana Geavlete, Laura Antohi, Giuseppe Rosano, Sean Collins, Filippo Crea   +15 more
wiley   +1 more source

Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry. [PDF]

BACKGROUND Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR.
Ruberti, Andrea Alberto, Latib, Azeem, Hagemeyer, Daniel, Piazza, Nicolo, Fam, Neil P, Bouchat, Marine, Ong, Geraldine, Kargoli, Faraj, Deva, Djeven P, Boiago, Mauro, Peterson, Mark D, Merdad, Anas, Modine, Thomas, Praz, Fabien Daniel, Sierra, Laura Villegas, Stolz, Lukas, Hausleiter, Jörg, Moschovitis, Aris, Dumonteil, Nicolas, Taramasso, Maurizio   +19 more
core   +2 more sources

Quality of life after transcatheter tricuspid valve repair: results from the Tri.FR trial

ESC Heart Failure, Volume 12, Issue 4, Page 3053-3061, August 2025.
This study is one of the first randomised trials to demonstrate that transcatheter tricuspid valve repair (T‐TEER) yields substantial and sustained improvements in quality of life across multiple domains, beyond clinical and echocardiographic outcomes.
Sabina Istratoaie, Pascal de Groote, Nicole Karam, Jean‐Noel Trochu, Guillaume Leurent, Augustin Coisne, Pierre‐Yves Le Roux, Anne Ganivet, Anne Bernard, Antoinette Neylon, Romain Pierrard, Florent Le Ven, François Picard, Nicolas Piriou, Thierry Laperche, Jerome Jouan, Amedeo Anselmi, Vincent Auffret, Emmanuel Oger, Erwan Donal   +19 more
wiley   +1 more source

Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure

, 2020
Objectives: The goal of this study was to evaluate the effect of transcatheter edge-to-edge tricuspid valve repair (TTVR) for severe tricuspid regurgitation (TR) on hospitalization for heart failure (HHF) and HF-related endpoints.
Ong G, Miura M, Gavazzoni M, Massberg S, Thiele H, Nabauer M, Edwards J, Gulmez G, Fam NP, Besler C, Zuber M, Taramasso M, Stolz L, Deseive S, Hausleiter J, Connelly KA, Pozzoli A, Unterhuber M, Rommel KP, Maisano F, Lurz P, Orban M, Ho EC, Braun D   +23 more
core   +1 more source